Silke U Oberdorf-Maass

Learn More
Although many β1-receptor antagonists and β2-receptor agonists have been used in pharmacotherapy for many years their pharmacological properties at all three known subtypes of β-adrenergic receptors(More)
Structural remodelling occurring before, due to the underlying heart disease, and during atrial fibrillation (AF) sets the stage for permanent AF. Current therapy in AF aims to maintain sinus rhythm(More)
  • 1